OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
August 01, 2009
Dietary supplements function like drugs and are marketed like drugs. They should be regulated like ducks.
The Belgian drugmaker is pursuing a sale, inking deals, issuing debt, and launching a power drug for Parkinson's-all at once.
Pressure to expand healthcare puts drug pricing, marketing, and innovation on the negotiating table.
Business schools must prepare students for the post-recession economy, not teach them principles applicable to 2003.
With the biotech industry reeling from the recession, big drugmakers hold all the cards when it comes to making deals, but picking a winner is still a gamble. Here are 10 to place stakes on.
Innovative pharmaceutical companies are reaching out to physicians and consumers in an effort to get patients to take their medicine.
In an era of blurred channels and information clutter, it is critical for brand managers to develop a unified strategy that bridges the gaps between audiences.
Through innovative patient compliance programs, manufacturers are taking steps to meet the needs of patients and the pharma industry.